ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

I-Pharm Consulting Group Limited

I-Pharm Consulting Group Limited is an active company incorporated on 29 September 2017 with the registered office located in London, City of London. I-Pharm Consulting Group Limited was registered 8 years ago.
Status
Active
Active since 6 years ago
Company No
10988701
Private limited company
Age
8 years
Incorporated 29 September 2017
Size
Medium
Turnover is under £54M
Under 250 employees
Confirmation
Submitted
Dated 18 February 2025 (11 months ago)
Next confirmation dated 18 February 2026
Due by 4 March 2026 (1 month remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Group
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
Moor Place, 1 Fore Street Avenue
Fore Street Avenue
London
EC2Y 9DT
England
Address changed on 13 Jan 2025 (1 year ago)
Previous address was Level 7 8 Devonshire Square London EC2M 4YJ England
Telephone
020 31892299
Email
Unreported
People
Officers
4
Shareholders
5
Controllers (PSC)
1
Director • Secretary • British • Lives in UK • Born in Apr 1964
Director • British • Lives in UK • Born in May 1975
Director • British,irish • Lives in England • Born in Jun 1979
I-Pharm Trustees Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
I-Pharm Consulting Limited
Issam Adil Al-Tarafi, Steven James Lamport-Went, and 1 more are mutual people.
Active
I-Pharm Consulting International Limited
Issam Adil Al-Tarafi, Steven James Lamport-Went, and 1 more are mutual people.
Active
Parallel Consulting Limited
Issam Adil Al-Tarafi and Steven James Lamport-Went are mutual people.
Active
Apollo Solutions Limited
Issam Adil Al-Tarafi and Steven James Lamport-Went are mutual people.
Active
Parallel Group Limited
Issam Adil Al-Tarafi and Steven James Lamport-Went are mutual people.
Active
White Knight Ventures Limited
Steven James Lamport-Went is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£1.82M
Increased by £708K (+64%)
Turnover
£18.12M
Decreased by £10.19M (-36%)
Employees
66
Decreased by 47 (-42%)
Total Assets
£5.44M
Decreased by £3.38M (-38%)
Total Liabilities
-£1.19M
Decreased by £1.82M (-60%)
Net Assets
£4.25M
Decreased by £1.56M (-27%)
Debt Ratio (%)
22%
Decreased by 12.24% (-36%)
Latest Activity
New Charge Registered
2 Months Ago on 21 Nov 2025
Stephen Peter Mcananey (PSC) Resigned
2 Months Ago on 21 Nov 2025
I-Pharm Trustees Limited (PSC) Appointed
2 Months Ago on 21 Nov 2025
Group Accounts Submitted
3 Months Ago on 30 Sep 2025
Own Shares Purchased
10 Months Ago on 3 Mar 2025
Confirmation Submitted
11 Months Ago on 19 Feb 2025
Colin John Lynam Resigned
11 Months Ago on 31 Jan 2025
Mr Issam Adil Al-Tarafi Details Changed
1 Year Ago on 13 Jan 2025
Mr Steven James Lamport-Went Details Changed
1 Year Ago on 13 Jan 2025
Mr Steven James Lamport-Went Details Changed
1 Year Ago on 13 Jan 2025
Get Credit Report
Discover I-Pharm Consulting Group Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Resolutions
Submitted on 2 Dec 2025
Memorandum and Articles of Association
Submitted on 2 Dec 2025
Change of share class name or designation
Submitted on 28 Nov 2025
Particulars of variation of rights attached to shares
Submitted on 28 Nov 2025
Notification of I-Pharm Trustees Limited as a person with significant control on 21 November 2025
Submitted on 27 Nov 2025
Cessation of Stephen Peter Mcananey as a person with significant control on 21 November 2025
Submitted on 27 Nov 2025
Statement of capital following an allotment of shares on 21 November 2025
Submitted on 27 Nov 2025
Statement of capital following an allotment of shares on 21 November 2025
Submitted on 27 Nov 2025
Statement of capital following an allotment of shares on 21 November 2025
Submitted on 27 Nov 2025
Statement of capital following an allotment of shares on 21 November 2025
Submitted on 27 Nov 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year